342 related articles for article (PubMed ID: 25910931)
1. Risk factors and derived formosa score for intravenous immunoglobulin unresponsiveness in Taiwanese children with Kawasaki disease.
Lin MT; Chang CH; Sun LC; Liu HM; Chang HW; Chen CA; Chiu SN; Lu CW; Chang LY; Wang JK; Wu MH
J Formos Med Assoc; 2016 May; 115(5):350-5. PubMed ID: 25910931
[TBL] [Abstract][Full Text] [Related]
2. Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease.
Kobayashi T; Inoue Y; Takeuchi K; Okada Y; Tamura K; Tomomasa T; Kobayashi T; Morikawa A
Circulation; 2006 Jun; 113(22):2606-12. PubMed ID: 16735679
[TBL] [Abstract][Full Text] [Related]
3. Serum albumin level predicts initial intravenous immunoglobulin treatment failure in Kawasaki disease.
Kuo HC; Liang CD; Wang CL; Yu HR; Hwang KP; Yang KD
Acta Paediatr; 2010 Oct; 99(10):1578-83. PubMed ID: 20491705
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory cytokines as predictors of resistance to intravenous immunoglobulin therapy in Kawasaki disease patients.
Sato S; Kawashima H; Kashiwagi Y; Hoshika A
Int J Rheum Dis; 2013 Apr; 16(2):168-72. PubMed ID: 23773640
[TBL] [Abstract][Full Text] [Related]
5. Defining the risk of first intravenous immunoglobulin unresponsiveness in non-Asian patients with Kawasaki disease.
Piram M; Darce Bello M; Tellier S; Di Filippo S; Boralevi F; Madhi F; Meinzer U; Cimaz R; Piedvache C; Koné-Paut I
Sci Rep; 2020 Feb; 10(1):3125. PubMed ID: 32080307
[TBL] [Abstract][Full Text] [Related]
6. Indicators of unresponsiveness after initial i.v. immunoglobulin treatment in acute Kawasaki disease.
Hashimoto I
Pediatr Int; 2019 Jul; 61(7):641-646. PubMed ID: 31132210
[TBL] [Abstract][Full Text] [Related]
7. Comparison of risk scores for predicting intravenous immunoglobulin resistance in Taiwanese patients with Kawasaki disease.
Huang CN; Wu FF; Chang YM; Huang HC; Lin MT; Wang JK; Wu MH
J Formos Med Assoc; 2021 Oct; 120(10):1884-1889. PubMed ID: 33358267
[TBL] [Abstract][Full Text] [Related]
8. Prediction of intravenous immunoglobulin resistance in Kawasaki disease in an East China population.
Tang Y; Yan W; Sun L; Huang J; Qian W; Ding Y; Lv H
Clin Rheumatol; 2016 Nov; 35(11):2771-2776. PubMed ID: 27491972
[TBL] [Abstract][Full Text] [Related]
9. [Therapeutic effectiveness of intravenous immunoglobulin at 1 g/kg and 2 g/kg on Kawasaki disease: a comparative and follow-up study].
Qin LJ; Wang HW; Hu XF; Liu QJ; Shi H; Wei YX; Chen QJ; Cheng PX
Zhonghua Er Ke Za Zhi; 2006 Dec; 44(12):891-5. PubMed ID: 17254453
[TBL] [Abstract][Full Text] [Related]
10. A comparison of efficacy of six prediction models for intravenous immunoglobulin resistance in Kawasaki disease.
Qian W; Tang Y; Yan W; Sun L; Lv H
Ital J Pediatr; 2018 Mar; 44(1):33. PubMed ID: 29523168
[TBL] [Abstract][Full Text] [Related]
11. Risk factors of immunoglobulin resistance and coronary complications in children with Kawasaki disease.
Berdej-Szczot E; Małecka-Tendera E; Gawlik T; Firek-Pędras M; Szydłowski L; Gawlik A
Kardiol Pol; 2017; 75(3):261-266. PubMed ID: 27995598
[TBL] [Abstract][Full Text] [Related]
12. IL-1B polymorphism in association with initial intravenous immunoglobulin treatment failure in Taiwanese children with Kawasaki disease.
Weng KP; Hsieh KS; Ho TY; Huang SH; Lai CR; Chiu YT; Huang SC; Lin CC; Hwang YT; Ger LP
Circ J; 2010 Mar; 74(3):544-51. PubMed ID: 20081319
[TBL] [Abstract][Full Text] [Related]
13. Assessment of intravenous immunoglobulin non-responders in Kawasaki disease.
Hwang JY; Lee KY; Rhim JW; Youn YS; Oh JH; Han JW; Lee JS; Burgner D
Arch Dis Child; 2011 Nov; 96(11):1088-90. PubMed ID: 20551193
[TBL] [Abstract][Full Text] [Related]
14. Do cytokines correlate with refractory Kawasaki disease in children?
Wang Y; Qian SY; Yuan Y; Wang Q; Gao L; Chen X; Yu X; Zhen Z
Clin Chim Acta; 2020 Jul; 506():222-227. PubMed ID: 32156603
[TBL] [Abstract][Full Text] [Related]
15. Shock and unresponsiveness to repeated courses of intravenous immunoglobulin in Kawasaki disease: a nationwide database study.
Liang YC; Chang CH; Lin MT; Kao FY; Huang SK; Wu MH
Pediatr Res; 2020 Apr; 87(5):961-966. PubMed ID: 31711068
[TBL] [Abstract][Full Text] [Related]
16. Early Appearance of Principal Symptoms of Kawasaki Disease is a Risk Factor for Intravenous Immunoglobulin Resistance.
Tajima M; Shiozawa Y; Kagawa J
Pediatr Cardiol; 2015 Aug; 36(6):1159-65. PubMed ID: 25753685
[TBL] [Abstract][Full Text] [Related]
17. Importance of C-reactive protein level in predicting non-response to additional intravenous immunoglobulin treatment in children with Kawasaki disease: a retrospective study.
Iwashima S; Kimura M; Ishikawa T; Ohzeki T
Clin Drug Investig; 2011; 31(3):191-9. PubMed ID: 21456105
[TBL] [Abstract][Full Text] [Related]
18. Role of the Egami score to predict immunoglobulin resistance in Kawasaki disease among a Western Mediterranean population.
Sánchez-Manubens J; Antón J; Bou R; Iglesias E; Calzada-Hernandez J; Borlan S; Gimenez-Roca C; Rivera J;
Rheumatol Int; 2016 Jul; 36(7):905-10. PubMed ID: 27215220
[TBL] [Abstract][Full Text] [Related]
19. Early treatment with intravenous immunoglobulin in patients with Kawasaki disease.
Tse SM; Silverman ED; McCrindle BW; Yeung RS
J Pediatr; 2002 Apr; 140(4):450-5. PubMed ID: 12006960
[TBL] [Abstract][Full Text] [Related]
20. A low-frequency IL4R locus variant in Japanese patients with intravenous immunoglobulin therapy-unresponsive Kawasaki disease.
Amano Y; Akazawa Y; Yasuda J; Yoshino K; Kojima K; Kobayashi N; Matsuzaki S; Nagasaki M; Kawai Y; Minegishi N; Ishida N; Motoki N; Hachiya A; Nakazawa Y; Yamamoto M; Koike K; Takeshita T
Pediatr Rheumatol Online J; 2019 Jul; 17(1):34. PubMed ID: 31269967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
